Roche Holding AG (RHHVF) Financials

RHHVF Assets vs Liabilities

DateAssetsLiabilities
Dec. 31, 2025 127.0 billion 79.2 billion
June 30, 2025 119.5 billion 77.8 billion
Dec. 31, 2024 112.6 billion 72.6 billion
June 30, 2024 106.4 billion 69.9 billion

RHHVF Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 11.6 billion ?
June 30, 2025 6.8 billion 494.4 million
Dec. 31, 2024 9.8 billion 495.4 million
June 30, 2024 6.9 billion 452.0 million

RHHVF Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
Dec. 31, 2025 6.9 billion
June 30, 2025 9.3 billion
Dec. 31, 2024 3.2 billion
June 30, 2024 7.0 billion

RHHVF Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 19.5 billion 36.2 billion 1.6 billion
June 30, 2025 15.2 billion 35.4 billion 2.0 billion
Dec. 31, 2024 19.1 billion 35.5 billion 1.9 billion
June 30, 2024 9.8 billion 33.5 billion 1.9 billion

RHHVF Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 ?
June 30, 2025 ?
Dec. 31, 2024 ?
June 30, 2024 ?

RHHVF Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 2.6 billion 8.4 billion 10.3 billion -
June 30, 2025 2.1 billion 8.4 billion 8.3 billion -
Dec. 31, 2024 3.6 billion 8.8 billion 8.0 billion -
June 30, 2024 1.9 billion 8.2 billion 7.2 billion -

RHHVF Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 37.4 billion 11.2 billion
June 30, 2025 40.2 billion 9.8 billion
Dec. 31, 2024 35.0 billion 9.7 billion
June 30, 2024 34.2 billion 8.3 billion

RHHVF

Price: $404

52 week price:
277.00
490.33

Dividend Yield: 2.50%

5-year range yield:
2.50%
4.11%

Forward Dividend Yield: 3.21%

Payout Ratio: 69.86%

Payout Ratio Range:
-44.64%
132.77%

Dividend Per Share: 12.79 USD

Earnings Per Share: 20.11 USD

P/E Ratio: 21.83

Exchange: OQX

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: Switzerland

Market Capitalization: 349.5 billion

Average Dividend Frequency: 1

Years Paying Dividends: 37

DGR3: 30.00%

DGR5: 23.68%

DGR10: 12.92%

DGR20: 12.90%

Links: